title: Influence of prebiotics, probiotics and protein ingredients on mycotoxin bioaccessibility.
abstract: The aim of this study was to investigate the influence of prebiotic compounds (cellulose and inulin), food ingredients (milk whey, β-lactoglobulin and calcium caseinate) and several probiotic microorganisms on the bioaccessibility of beauvericin (BEA), enniatins (ENs A, A1, B, B1), deoxynivalenol (DON) and zearalenone (ZEA) present in wheat crispy bread produced with wheat flour previously fermented with F. tricinctum, F. culmorum and G. zeae. The bioaccessibility of mycotoxins was determined by a dynamic simulated gastrointestinal digestion system, imitating the human digestive physiological conditions of the gastrointestinal tract. Mycotoxins were determined in the simulated intestinal fluids by liquid chromatography-tandem mass spectrometry (LC-MS/MS). EN bioaccessibility ranged from 15.1 to 30.6%, whereas the values evidenced for BEA ranged from 12 to 19%. DON showed bioaccessibility data ranging from 0.8 to 5.6% whereas for ZEA the data evidenced ranged from 26 to 44%. The bioaccessibility reduction evidenced using probiotic microorganisms for the mycotoxins studied ranged from 21 to 27.1% for ENs, from 29 to 39.7% for DON, from 41 to 57% for ZEA and from 6.6 to 10.5% for BEA. The addition of prebiotic and bioactive microorganisms decreased the bioaccessibility of mycotoxins, with a concentration-dependent behavior, thus being a potential strategy for reducing human exposure to these minor mycotoxins.
authors: Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100 Burjassot, Spain. giuseppe.meca@uv.es.
authors: M
authors: M
authors: Ferrer
authors: L
authors: L
authors: Manyes
authors: J
authors: J
authors: Mañes
authors: G
authors: G
authors: Meca
mesh_terms: D000931:Antidotes / Q000627:therapeutic use; D001644:Bifidobacterium / Q000254:growth & development / Q000378:metabolism; D001682:Biological Availability; D001939:Bread / Q000032:analysis; D004044:Dietary Proteins / Q000627:therapeutic use*; D004063:Digestion; D004881:Ergotism / Q000517:prevention & control*; D005285:Fermentation; D005433:Flour / Q000032:analysis / Q000382:microbiology; D005506:Food Contamination; D005670:Fusarium / Q000254:growth & development / Q000378:metabolism; D005766:Gastrointestinal Contents / Q000737:chemistry / Q000382:microbiology; D041981:Gastrointestinal Tract / Q000378:metabolism* / Q000382:microbiology; D005874:Gibberella / Q000254:growth & development / Q000378:metabolism; D006801:Humans; D007778:Lactobacillus / Q000254:growth & development / Q000378:metabolism; D008954:Models, Biological; D009183:Mycotoxins / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000302:isolation & purification / Q000633:toxicity; D011042:Poisons / Q000032:analysis / Q000302:isolation & purification / Q000633:toxicity; D056692:Prebiotics / Q000008:administration & dosage*; D019936:Probiotics / Q000627:therapeutic use*; D066007:Toxicokinetics
chemical_list: D000931:Antidotes; D004044:Dietary Proteins; D009183:Mycotoxins; D011042:Poisons; D056692:Prebiotics